nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—chronic obstructive pulmonary disease	0.743	1	CbGaD
Cefazolin—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.00654	0.0315	CcSEcCtD
Cefazolin—TPMT—Methylation—CYP1A2—chronic obstructive pulmonary disease	0.00603	0.148	CbGpPWpGaD
Cefazolin—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.0047	0.0226	CcSEcCtD
Cefazolin—Oral candidiasis—Tiotropium—chronic obstructive pulmonary disease	0.0047	0.0226	CcSEcCtD
Cefazolin—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.0046	0.0221	CcSEcCtD
Cefazolin—Oral candidiasis—Arformoterol—chronic obstructive pulmonary disease	0.00379	0.0182	CcSEcCtD
Cefazolin—Oral candidiasis—Formoterol—chronic obstructive pulmonary disease	0.00379	0.0182	CcSEcCtD
Cefazolin—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.00346	0.0166	CcSEcCtD
Cefazolin—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.0033	0.0159	CcSEcCtD
Cefazolin—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.0137	CcSEcCtD
Cefazolin—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00283	0.0136	CcSEcCtD
Cefazolin—Mouth ulceration—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.013	CcSEcCtD
Cefazolin—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00266	0.0128	CcSEcCtD
Cefazolin—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.0023	0.011	CcSEcCtD
Cefazolin—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.011	CcSEcCtD
Cefazolin—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0021	0.0101	CcSEcCtD
Cefazolin—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00206	0.00989	CcSEcCtD
Cefazolin—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00978	CcSEcCtD
Cefazolin—Hypertonia—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00958	CcSEcCtD
Cefazolin—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00953	CcSEcCtD
Cefazolin—Cefdinir—MPO—chronic obstructive pulmonary disease	0.00178	0.224	CrCbGaD
Cefazolin—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00788	CcSEcCtD
Cefazolin—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00782	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00741	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00741	CcSEcCtD
Cefazolin—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00724	CcSEcCtD
Cefazolin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00716	CcSEcCtD
Cefazolin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00707	CcSEcCtD
Cefazolin—TPMT—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00147	0.036	CbGpPWpGaD
Cefazolin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00704	CcSEcCtD
Cefazolin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00701	CcSEcCtD
Cefazolin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.0067	CcSEcCtD
Cefazolin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00665	CcSEcCtD
Cefazolin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00646	CcSEcCtD
Cefazolin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00643	CcSEcCtD
Cefazolin—Cefotetan—ALB—chronic obstructive pulmonary disease	0.00132	0.166	CrCbGaD
Cefazolin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00629	CcSEcCtD
Cefazolin—TPMT—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00127	0.0312	CbGpPWpGaD
Cefazolin—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00611	CcSEcCtD
Cefazolin—TPMT—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00126	0.0308	CbGpPWpGaD
Cefazolin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00599	CcSEcCtD
Cefazolin—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00596	CcSEcCtD
Cefazolin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00584	CcSEcCtD
Cefazolin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00576	CcSEcCtD
Cefazolin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00569	CcSEcCtD
Cefazolin—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00562	CcSEcCtD
Cefazolin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00557	CcSEcCtD
Cefazolin—Cefpiramide—ALB—chronic obstructive pulmonary disease	0.00115	0.144	CrCbGaD
Cefazolin—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00552	CcSEcCtD
Cefazolin—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00551	CcSEcCtD
Cefazolin—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00549	CcSEcCtD
Cefazolin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00542	CcSEcCtD
Cefazolin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00538	CcSEcCtD
Cefazolin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00538	CcSEcCtD
Cefazolin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00534	CcSEcCtD
Cefazolin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00517	CcSEcCtD
Cefazolin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00517	CcSEcCtD
Cefazolin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00513	CcSEcCtD
Cefazolin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00512	CcSEcCtD
Cefazolin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.0051	CcSEcCtD
Cefazolin—TPMT—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.0259	CbGpPWpGaD
Cefazolin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00507	CcSEcCtD
Cefazolin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00503	CcSEcCtD
Cefazolin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00483	CcSEcCtD
Cefazolin—Cefonicid—ALB—chronic obstructive pulmonary disease	0.001	0.126	CrCbGaD
Cefazolin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000993	0.00478	CcSEcCtD
Cefazolin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000981	0.00472	CcSEcCtD
Cefazolin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000979	0.00471	CcSEcCtD
Cefazolin—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.00465	CcSEcCtD
Cefazolin—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000967	0.00465	CcSEcCtD
Cefazolin—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000947	0.00455	CcSEcCtD
Cefazolin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000937	0.0045	CcSEcCtD
Cefazolin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000923	0.00444	CcSEcCtD
Cefazolin—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.00439	CcSEcCtD
Cefazolin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000896	0.00431	CcSEcCtD
Cefazolin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000893	0.00429	CcSEcCtD
Cefazolin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000892	0.00429	CcSEcCtD
Cefazolin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000892	0.00429	CcSEcCtD
Cefazolin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000891	0.00428	CcSEcCtD
Cefazolin—TPMT—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000882	0.0216	CbGpPWpGaD
Cefazolin—Cefmetazole—ALB—chronic obstructive pulmonary disease	0.00088	0.111	CrCbGaD
Cefazolin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.0042	CcSEcCtD
Cefazolin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00087	0.00418	CcSEcCtD
Cefazolin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000859	0.00413	CcSEcCtD
Cefazolin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000859	0.00413	CcSEcCtD
Cefazolin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000845	0.00406	CcSEcCtD
Cefazolin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000841	0.00404	CcSEcCtD
Cefazolin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000841	0.00404	CcSEcCtD
Cefazolin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000831	0.004	CcSEcCtD
Cefazolin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000826	0.00397	CcSEcCtD
Cefazolin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000824	0.00396	CcSEcCtD
Cefazolin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000811	0.0039	CcSEcCtD
Cefazolin—TPMT—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000811	0.0199	CbGpPWpGaD
Cefazolin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000802	0.00386	CcSEcCtD
Cefazolin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000802	0.00386	CcSEcCtD
Cefazolin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000798	0.00384	CcSEcCtD
Cefazolin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000798	0.00384	CcSEcCtD
Cefazolin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000784	0.00377	CcSEcCtD
Cefazolin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000773	0.00372	CcSEcCtD
Cefazolin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000772	0.00371	CcSEcCtD
Cefazolin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000763	0.00367	CcSEcCtD
Cefazolin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000763	0.00367	CcSEcCtD
Cefazolin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.00364	CcSEcCtD
Cefazolin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000756	0.00363	CcSEcCtD
Cefazolin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000756	0.00363	CcSEcCtD
Cefazolin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000753	0.00362	CcSEcCtD
Cefazolin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000748	0.0036	CcSEcCtD
Cefazolin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00359	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000745	0.0183	CbGpPWpGaD
Cefazolin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00074	0.00356	CcSEcCtD
Cefazolin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00074	0.00356	CcSEcCtD
Cefazolin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00074	0.00356	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000736	0.018	CbGpPWpGaD
Cefazolin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000734	0.00353	CcSEcCtD
Cefazolin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000734	0.00353	CcSEcCtD
Cefazolin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000725	0.00349	CcSEcCtD
Cefazolin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.00347	CcSEcCtD
Cefazolin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000719	0.00346	CcSEcCtD
Cefazolin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000717	0.00345	CcSEcCtD
Cefazolin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000714	0.00343	CcSEcCtD
Cefazolin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000711	0.00342	CcSEcCtD
Cefazolin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000711	0.00342	CcSEcCtD
Cefazolin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.0034	CcSEcCtD
Cefazolin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000708	0.0034	CcSEcCtD
Cefazolin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000707	0.0034	CcSEcCtD
Cefazolin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000705	0.00339	CcSEcCtD
Cefazolin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000704	0.00338	CcSEcCtD
Cefazolin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000702	0.00338	CcSEcCtD
Cefazolin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000702	0.00338	CcSEcCtD
Cefazolin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000699	0.00336	CcSEcCtD
Cefazolin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000693	0.00333	CcSEcCtD
Cefazolin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000688	0.00331	CcSEcCtD
Cefazolin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000682	0.00328	CcSEcCtD
Cefazolin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000682	0.00328	CcSEcCtD
Cefazolin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000679	0.00326	CcSEcCtD
Cefazolin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.00326	CcSEcCtD
Cefazolin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.00326	CcSEcCtD
Cefazolin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000679	0.00326	CcSEcCtD
Cefazolin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000677	0.00325	CcSEcCtD
Cefazolin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000671	0.00323	CcSEcCtD
Cefazolin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00067	0.00322	CcSEcCtD
Cefazolin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00067	0.00322	CcSEcCtD
Cefazolin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000668	0.00321	CcSEcCtD
Cefazolin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00321	CcSEcCtD
Cefazolin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000667	0.0032	CcSEcCtD
Cefazolin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000665	0.0032	CcSEcCtD
Cefazolin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000665	0.0032	CcSEcCtD
Cefazolin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000663	0.00319	CcSEcCtD
Cefazolin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000658	0.00316	CcSEcCtD
Cefazolin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000655	0.00315	CcSEcCtD
Cefazolin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.0031	CcSEcCtD
Cefazolin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.00308	CcSEcCtD
Cefazolin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.00308	CcSEcCtD
Cefazolin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00304	CcSEcCtD
Cefazolin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00304	CcSEcCtD
Cefazolin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.00304	CcSEcCtD
Cefazolin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00298	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000619	0.0152	CbGpPWpGaD
Cefazolin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00296	CcSEcCtD
Cefazolin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00296	CcSEcCtD
Cefazolin—TPMT—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00061	0.015	CbGpPWpGaD
Cefazolin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00292	CcSEcCtD
Cefazolin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00292	CcSEcCtD
Cefazolin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000604	0.0029	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000598	0.0147	CbGpPWpGaD
Cefazolin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00287	CcSEcCtD
Cefazolin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000595	0.00286	CcSEcCtD
Cefazolin—Cefoperazone—ALB—chronic obstructive pulmonary disease	0.000589	0.0742	CrCbGaD
Cefazolin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00282	CcSEcCtD
Cefazolin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00282	CcSEcCtD
Cefazolin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.0028	CcSEcCtD
Cefazolin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000576	0.00277	CcSEcCtD
Cefazolin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00276	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00057	0.014	CbGpPWpGaD
Cefazolin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00273	CcSEcCtD
Cefazolin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00273	CcSEcCtD
Cefazolin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00267	CcSEcCtD
Cefazolin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000556	0.00267	CcSEcCtD
Cefazolin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00267	CcSEcCtD
Cefazolin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000546	0.00263	CcSEcCtD
Cefazolin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000546	0.00263	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000544	0.0133	CbGpPWpGaD
Cefazolin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.0026	CcSEcCtD
Cefazolin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000541	0.0026	CcSEcCtD
Cefazolin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000541	0.0026	CcSEcCtD
Cefazolin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.0026	CcSEcCtD
Cefazolin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00259	CcSEcCtD
Cefazolin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00259	CcSEcCtD
Cefazolin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00258	CcSEcCtD
Cefazolin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00257	CcSEcCtD
Cefazolin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00255	CcSEcCtD
Cefazolin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00255	CcSEcCtD
Cefazolin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00253	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000522	0.0128	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000519	0.0127	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000518	0.0127	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000516	0.0127	CbGpPWpGaD
Cefazolin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00248	CcSEcCtD
Cefazolin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00246	CcSEcCtD
Cefazolin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000511	0.00246	CcSEcCtD
Cefazolin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00246	CcSEcCtD
Cefazolin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00245	CcSEcCtD
Cefazolin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00245	CcSEcCtD
Cefazolin—TPMT—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000509	0.0125	CbGpPWpGaD
Cefazolin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.00244	CcSEcCtD
Cefazolin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.00241	CcSEcCtD
Cefazolin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0005	0.0024	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000494	0.0121	CbGpPWpGaD
Cefazolin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.00237	CcSEcCtD
Cefazolin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00232	CcSEcCtD
Cefazolin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000478	0.0023	CcSEcCtD
Cefazolin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000476	0.00229	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000474	0.0116	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000468	0.0115	CbGpPWpGaD
Cefazolin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000465	0.00224	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000465	0.0114	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000462	0.0113	CbGpPWpGaD
Cefazolin—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.000459	0.0578	CrCbGaD
Cefazolin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000458	0.0022	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00045	0.011	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000444	0.0109	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000443	0.0109	CbGpPWpGaD
Cefazolin—Cefalotin—ALB—chronic obstructive pulmonary disease	0.000402	0.0506	CrCbGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000398	0.00975	CbGpPWpGaD
Cefazolin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.00191	CcSEcCtD
Cefazolin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.00184	CcSEcCtD
Cefazolin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00184	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000381	0.00935	CbGpPWpGaD
Cefazolin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00183	CcSEcCtD
Cefazolin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00179	CcSEcCtD
Cefazolin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000369	0.00178	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000369	0.00906	CbGpPWpGaD
Cefazolin—Cephalexin—ALB—chronic obstructive pulmonary disease	0.000366	0.046	CrCbGaD
Cefazolin—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000365	0.00896	CbGpPWpGaD
Cefazolin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00175	CcSEcCtD
Cefazolin—TPMT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000362	0.00887	CbGpPWpGaD
Cefazolin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00172	CcSEcCtD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000355	0.00869	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000352	0.00862	CbGpPWpGaD
Cefazolin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00165	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00034	0.00834	CbGpPWpGaD
Cefazolin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000338	0.00162	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000338	0.00828	CbGpPWpGaD
Cefazolin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000333	0.0016	CcSEcCtD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000332	0.00814	CbGpPWpGaD
Cefazolin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000322	0.00155	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00032	0.00785	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000314	0.0077	CbGpPWpGaD
Cefazolin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.00148	CcSEcCtD
Cefazolin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000297	0.00143	CcSEcCtD
Cefazolin—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000297	0.00729	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000296	0.00726	CbGpPWpGaD
Cefazolin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00141	CcSEcCtD
Cefazolin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.00141	CcSEcCtD
Cefazolin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.00141	CcSEcCtD
Cefazolin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000291	0.0014	CcSEcCtD
Cefazolin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.0014	CcSEcCtD
Cefazolin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00134	CcSEcCtD
Cefazolin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00133	CcSEcCtD
Cefazolin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00133	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000272	0.00667	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000271	0.00663	CbGpPWpGaD
Cefazolin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Cefazolin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00128	CcSEcCtD
Cefazolin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00128	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000265	0.0065	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000258	0.00632	CbGpPWpGaD
Cefazolin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000249	0.0012	CcSEcCtD
Cefazolin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00117	CcSEcCtD
Cefazolin—ABCC4—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00024	0.00589	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00024	0.00587	CbGpPWpGaD
Cefazolin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00115	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000238	0.00583	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000237	0.00581	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000236	0.00579	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000235	0.00575	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000234	0.00573	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GC—chronic obstructive pulmonary disease	0.000233	0.00571	CbGpPWpGaD
Cefazolin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00111	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00023	0.00564	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000227	0.00558	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000227	0.00557	CbGpPWpGaD
Cefazolin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00107	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000223	0.00548	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000218	0.00534	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000217	0.00531	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000217	0.00531	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000216	0.0053	CbGpPWpGaD
Cefazolin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00103	CcSEcCtD
Cefazolin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00102	CcSEcCtD
Cefazolin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00102	CcSEcCtD
Cefazolin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00102	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000209	0.00512	CbGpPWpGaD
Cefazolin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000965	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000192	0.00471	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000173	0.00423	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000156	0.00384	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000156	0.00383	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000154	0.00377	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000149	0.00365	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000148	0.00362	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000144	0.00352	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000137	0.00335	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000137	0.00335	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000127	0.00312	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000126	0.00309	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000124	0.00304	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000123	0.00302	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000121	0.00296	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00012	0.00294	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00012	0.00294	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.00012	0.00294	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000119	0.00291	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000115	0.00282	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000108	0.00264	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000106	0.00261	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.00259	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000104	0.00255	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000103	0.00252	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000102	0.00251	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000101	0.00247	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000101	0.00247	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	9.81e-05	0.0024	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	9.75e-05	0.00239	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	9.58e-05	0.00235	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.54e-05	0.00234	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.54e-05	0.00234	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	9.22e-05	0.00226	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.88e-05	0.00218	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.83e-05	0.00216	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.71e-05	0.00213	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	8.7e-05	0.00213	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.11e-05	0.00199	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.81e-05	0.00191	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.75e-05	0.0019	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.7e-05	0.00189	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.69e-05	0.00189	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.48e-05	0.00183	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	7.08e-05	0.00174	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	7.08e-05	0.00173	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	7.02e-05	0.00172	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	6.94e-05	0.0017	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	6.85e-05	0.00168	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	6.74e-05	0.00165	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	6.72e-05	0.00165	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	6.59e-05	0.00162	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.52e-05	0.0016	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	6.5e-05	0.00159	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	6.37e-05	0.00156	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	6.24e-05	0.00153	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	6.19e-05	0.00152	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	6.19e-05	0.00152	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	6.18e-05	0.00151	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.15e-05	0.00151	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.71e-05	0.0014	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.62e-05	0.00138	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	5.36e-05	0.00131	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—chronic obstructive pulmonary disease	5.23e-05	0.00128	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	5.2e-05	0.00127	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	5.19e-05	0.00127	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—chronic obstructive pulmonary disease	5e-05	0.00123	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.97e-05	0.00122	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.81e-05	0.00118	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.7e-05	0.00115	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.69e-05	0.00115	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.57e-05	0.00112	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.54e-05	0.00111	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.49e-05	0.0011	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.37e-05	0.00107	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	4.34e-05	0.00106	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.33e-05	0.00106	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GC—chronic obstructive pulmonary disease	4.25e-05	0.00104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.95e-05	0.000968	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.91e-05	0.000959	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.58e-05	0.000877	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.39e-05	0.00083	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.28e-05	0.000805	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000771	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.14e-05	0.00077	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.1e-05	0.00076	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.04e-05	0.000746	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.88e-05	0.000707	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.79e-05	0.000685	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	2.7e-05	0.000663	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.35e-05	0.000577	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.32e-05	0.000569	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000562	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.25e-05	0.000551	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000513	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.000473	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.62e-05	0.000397	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.000394	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.000389	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.49e-05	0.000364	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.000362	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000343	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.22e-05	0.0003	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	9.11e-06	0.000223	CbGpPWpGaD
